JP2021527107A5 - - Google Patents
Info
- Publication number
- JP2021527107A5 JP2021527107A5 JP2020569836A JP2020569836A JP2021527107A5 JP 2021527107 A5 JP2021527107 A5 JP 2021527107A5 JP 2020569836 A JP2020569836 A JP 2020569836A JP 2020569836 A JP2020569836 A JP 2020569836A JP 2021527107 A5 JP2021527107 A5 JP 2021527107A5
- Authority
- JP
- Japan
- Prior art keywords
- chi
- inhibitor
- antibody
- agent according
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305729.8 | 2018-06-14 | ||
| EP18305729 | 2018-06-14 | ||
| PCT/EP2019/065617 WO2019238893A1 (en) | 2018-06-14 | 2019-06-13 | Treatment of placental chronic histiocytic intervillositis using an inhibitor of interleukin-1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021527107A JP2021527107A (ja) | 2021-10-11 |
| JP2021527107A5 true JP2021527107A5 (https=) | 2022-06-17 |
Family
ID=62791692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020569836A Pending JP2021527107A (ja) | 2018-06-14 | 2019-06-13 | インターロイキン−１の阻害薬を使用した胎盤性慢性組織球性絨毛間腔炎の治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210115131A1 (https=) |
| EP (1) | EP3807313A1 (https=) |
| JP (1) | JP2021527107A (https=) |
| CN (1) | CN112236453A (https=) |
| WO (1) | WO2019238893A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230110291A (ko) | 2020-11-18 | 2023-07-21 | 노파르티스 아게 | Nlrc4-gof 염증복합체병증의 치료에 사용하기 위한 이중특이적 항체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME00546B (me) * | 2000-02-21 | 2011-10-10 | Serono Lab | Korišćenje inhibitora il-18 |
| CN1565620A (zh) * | 2003-06-09 | 2005-01-19 | 上海复旦张江生物医药股份有限公司 | 白细胞介素－1受体拮抗剂治疗非典型性肺炎的用途 |
| CA2780976C (en) * | 2009-11-25 | 2020-03-31 | Hologic, Inc. | Detection of intraamniotic infection |
-
2019
- 2019-06-13 JP JP2020569836A patent/JP2021527107A/ja active Pending
- 2019-06-13 WO PCT/EP2019/065617 patent/WO2019238893A1/en not_active Ceased
- 2019-06-13 CN CN201980038401.7A patent/CN112236453A/zh active Pending
- 2019-06-13 US US17/251,059 patent/US20210115131A1/en not_active Abandoned
- 2019-06-13 EP EP19732299.3A patent/EP3807313A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jacobs et al. | Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor | |
| JP5337055B2 (ja) | 免疫性障害の処置のための組合せ治療 | |
| HRP20100014T1 (hr) | Uporaba il-23 i il-17 antagonista u liječenju autoimune očne upalne bolesti | |
| KR20160044045A (ko) | 염증성 질환에서 il-18 결합 단백질(ｉｌ-18ｂｐ) | |
| WO2020198064A1 (en) | Ophthalmic formulations and uses thereof | |
| JP2017501680A5 (https=) | ||
| CN115605201A (zh) | 血管紧张素ii 2型受体激动剂的新用途 | |
| Lin et al. | Expressions of chemokines and their receptors in the brain after heat stroke-induced cortical damage | |
| CN107405403A (zh) | 用于治疗纤维化的塞尼克韦罗 | |
| JP2021527107A5 (https=) | ||
| Bhatt et al. | Promising pharmacologic innovations in treating pulmonary fibrosis | |
| Şahin et al. | Reduced cerebrospinal fluid levels of interleukin-10 in children with febrile seizures | |
| Wang et al. | Renin-dependent hypertension in mice requires the NLRP3-inflammasome | |
| Guo et al. | Thalidomide alleviates postoperative pain and spatial memory deficit in aged rats | |
| JP2019502739A (ja) | レイノー現象および免疫異常を患う患者における全身性強皮症の予防治療に使用するためのｐ２ｙ１２受容体を阻害する物質 | |
| Han et al. | The first case series of cryopyrin-associated periodic syndrome in Korea | |
| Edye et al. | Epilepsy and the inflammasome: targeting inflammation as a novel therapeutic strategy for seizure disorders | |
| Man et al. | The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study | |
| Nemeth et al. | Inflammatory mechanisms contribute to microembolism-induced anxiety-like and depressive-like behaviors | |
| Di Domenico et al. | Xolair in asthma therapy: an overview | |
| CN112533675A (zh) | 通过递送抗OSMRβ抗体治疗皮肤疾病或病症 | |
| CN115942933A (zh) | 用于治疗气道疾病的(1r,3s)-3-((5-氰基-4-苯基噻唑-2-基)氨基甲酰基)环戊烷-1-羧酸及其衍生物 | |
| ES3049513T3 (en) | Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation | |
| Smargiassi et al. | Pharmacologic Treatment of IPF | |
| AU2021322599A1 (en) | Methods and compositions for treating SARS-CoV-2 infection using carboxyamidotriazole orotate |